Christoph Lengauer, PhD, MBA

Christoph Lengauer is a drug hunter with a proven track record in cancer drug discovery. He has contributed to the discovery, development, and approval of 10 drugs. He is a co-founder of Curie.Bio, a venture creation firm focused on helping founders select clinically important targets and build successful drug discovery companies. He previously held leadership roles at Blueprint Medicines, Third Rock Ventures, Sanofi, and Novartis.